Balchem Corporation (BCPC)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Balchem Corporation (BCPC)
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.
Key Insights
Critical company metrics and information
Share Price
$173.91Market Cap
$5.65 BillionTotal Outstanding Shares
32.51 Million SharesTotal Employees
1,300Dividend
$0.79 Per Share AnnuallyIPO Date
June 3, 1986SIC Description
Chemicals & Allied ProductsHomepage
https://www.balchem.com
Historical Stock Splits
If you bought 1 share of BCPC before January 22, 2007, you'd have 2.25 shares today.
Execution Date | Split Amount |
---|---|
January 21, 2010 | 3-for-2 |
January 22, 2007 | 3-for-2 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-34.64 Million |
Net Cash Flow, Continuing | $-6.30 Million |
Net Cash Flow From Financing Activities, Continuing | $-168.75 Million |
Net Cash Flow | $-3.26 Million |
Net Cash Flow From Operating Activities, Continuing | $197.09 Million |
Net Cash Flow From Financing Activities | $-168.75 Million |
Exchange Gains/Losses | $3.04 Million |
Net Cash Flow From Investing Activities, Continuing | $-34.64 Million |
Net Cash Flow From Operating Activities | $197.09 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Benefits Costs and Expenses | $787.14 Million |
Diluted Average Shares | $32.69 Million |
Net Income/Loss | $121.54 Million |
Income Tax Expense/Benefit | $33.70 Million |
Diluted Earnings Per Share | $3.72 |
Basic Earnings Per Share | $3.77 |
Nonoperating Income/Loss | $-18.56 Million |
Income/Loss Before Equity Method Investments | $155.24 Million |
Research and Development | $16.22 Million |
Gross Profit | $324.86 Million |
Net Income/Loss Available To Common Stockholders, Basic | $121.54 Million |
Revenues | $942.38 Million |
Income/Loss From Continuing Operations After Tax | $128.16 Million |
Operating Expenses | $156.13 Million |
Net Income/Loss Attributable To Parent | $121.54 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income Tax Expense/Benefit, Deferred | $-10.31 Million |
Income/Loss From Continuing Operations Before Tax | $155.24 Million |
Operating Income/Loss | $168.73 Million |
Basic Average Shares | $32.32 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Costs And Expenses | $787.14 Million |
Other Operating Expenses | $134.84 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Cost Of Revenue | $617.52 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Equity | $1.18 Billion |
Noncurrent Assets | $1.27 Billion |
Other Non-current Assets | $993.53 Million |
Current Liabilities | $109.44 Million |
Liabilities And Equity | $1.60 Billion |
Fixed Assets | $277.43 Million |
Wages | $17.55 Million |
Assets | $1.60 Billion |
Other Current Liabilities | $91.89 Million |
Other Current Assets | $207.48 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Liabilities | $419.72 Million |
Current Assets | $325.99 Million |
Inventory | $118.51 Million |
Noncurrent Liabilities | $310.28 Million |
Equity Attributable To Parent | $1.18 Billion |
Historical Dividends
Current dividend: $0.79 Per Share Annually
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Dec 4, 2023 | Jan 19, 2024 | Dec 27, 2023 | $0.79 | Annually |
Dec 6, 2022 | Jan 20, 2023 | Dec 27, 2022 | $0.71 | Annually |
Dec 17, 2020 | Jan 22, 2021 | Dec 28, 2020 | $0.58 | Annually |
Dec 18, 2019 | Jan 17, 2020 | Dec 30, 2019 | $0.52 | Annually |
Dec 12, 2018 | Jan 18, 2019 | Dec 26, 2018 | $0.47 | Annually |
Dec 13, 2017 | Jan 19, 2018 | Dec 27, 2017 | $0.42 | Annually |
Dec 13, 2016 | Jan 20, 2017 | Dec 27, 2016 | $0.38 | Annually |
Dec 15, 2015 | Jan 21, 2016 | Dec 28, 2015 | $0.34 | Annually |
Dec 19, 2014 | Jan 27, 2015 | Dec 29, 2014 | $0.3 | Annually |
Dec 13, 2013 | Jan 21, 2014 | Dec 23, 2013 | $0.26 | Annually |
Nov 30, 2012 | Dec 21, 2012 | Dec 14, 2012 | $0.22 | Annually |
Related Companies
View additional S&P 500 companies similar to Balchem Corporation (BCPC)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
â“’ 2024 Financhle. All Rights Reserved.